JNPMEDI

What JNPMEDI does

JNPMEDI is a privately held South Korean Life Science RDC (Research, Development, and Commercialization) company founded in 2020 and headquartered in Songdo, Incheon, with a Seoul government-relations office and newly established regional headquarters in Singapore (APAC) and Delaware, USA (AMERICA). The company provides Maven Clinical Cloud, a proprietary end-to-end clinical trial operations and data management platform composed of nine integrated modules: CDMS (data capture), Converter (AI-driven CDISC SDTM transformation), Safety (pharmacovigilance with self-developed FDA AS2 gateway integration), TMF (electronic trial master file), eCOA (decentralized trial patient outcomes), eRecruitment (online subject recruitment), VDR (virtual data room for licensing), Builder (database design), and Coder Express (AWS Bedrock-based NLP medical coding). The platform is supported by an AI Task Force and 'Zero Submission' long-term roadmap targeting regulatory data ecosystems by 2041.

JNPMEDI sells through a combination of recurring SaaS subscriptions (annual enterprise and usage-based tiers), on-demand Professional Services covering business strategy, clinical operations, regulatory affairs (FDA, EMA, PMDA, MFDS), statistical analysis, and licensing-out advisory, plus an AWS Managed Service Provider offering for cloud operations support. Named enterprise customers include Samjin Pharm, Daewoong Pharmaceutical, JW Pharmaceutical, Hurotics, and Microt, primarily Korean pharma and medical device companies pursuing domestic and US/EU regulatory approvals.

The business has scaled rapidly: headcount grew from 20 to 190 in approximately three years, revenue grew 500% in the most recently reported year driven by CRO services expansion, and cumulative funding reached 160 billion KRW led by Pavilion Capital (Temasek subsidiary). The company has assembled regulatory expertise including former FDA reviewers and MFDS veterans, holds CDISC Platinum membership, achieved ISO 13485 certification, and was the first Eastern-region company selected for an official poster session at CDISC EU Interchange 2026. Distribution is reinforced by strategic alliances with Naver (AI and co-investment), MCRA and IQVIA (US market entry), Avance Clinical and ProSciento (Australia/US clinical operations), and academic partnerships across Korean universities for talent development.

Name

JNPMEDI

Legal name

JNPMEDI Inc.

Website

https://jnpmedi.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

JNPMEDI is a South Korea-based digital healthcare company providing the Maven Clinical Cloud platform for end-to-end clinical trial data management, serving pharmaceutical, biotech, and medical device companies through SaaS subscriptions, AI-powered regulatory automation, and CRO professional services.

Ownership category

akta.pro rank

Product category

Clinical Trial Management Software

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial software
• Clinical data management
• CDISC SDTM conversion
• Pharmacovigilance solutions
• Regulatory consulting services

Headquarters

HQ city

Incheon

HQ country

South Korea

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Software Subscriptions (SaaS): Maven Clinical Cloud platform subscriptions with usage-based and tiered pricing models. Includes CDMS, Safety, eCOA, TMF, and other clinical trial management modules.
2. Professional Services: Clinical trial consulting, regulatory strategy (FDA, CE, MFDS), clinical operations, data management, statistical analysis, and project management services.
3. AWS MSP Services: Cloud management and optimization services for pharmaceutical and biotech companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

JNPMEDI sells the Maven Clinical Cloud, a proprietary cloud platform for clinical trial data collection, management, and regulatory submission (including CDMS, SDTM Converter, Safety/pharmacovigilance, eTMF, eCOA, eRecruitment, VDR, and AI medical coding modules). It wraps this platform with on-demand Professional Services covering clinical operations, regulatory strategy (FDA, CE, MFDS), and licensing support, plus AWS Managed Service Provider offerings, for pharmaceutical, biotech, and medical device clients.

Product overview

JNPMEDI is a Life Science RDC (Research, Development, and Commercialization) company offering a unified platform architecture centered on Maven Clinical Cloud, with integrated modules including Maven CDMS (data collection/management), Maven Converter (SDTM data transformation), Maven Safety (pharmacovigilance reporting), Maven TMF (document management), Maven eCOA (decentralized trials), Maven eRecruitment (patient recruitment), Maven VDR (secure data room), Maven Coder Express (AI medical coding), and Maven Builder (database design). The company also provides Professional Services and AWS MSP Service as complementary offerings, enabling pharmaceutical, biotech, and medical device companies to advance products from business strategy through clinical trials, regulatory approval, and commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• Maven Clinical Cloud: Proprietary end-to-end clinical trial operations and data management cloud platform supporting CDMS, eTMF, Safety, eCOA, and eRecruitment modules.
• Maven CDMS
• Maven Converter
• Maven Safety
• Maven TMF
• Maven eCOA
• Maven eRecruitment
• Maven Builder
• Maven Coder Express
• Maven VDR
• JNPMEDI CONNECT
• JNPMEDI Partners
• FDA Expert Solution

Products and services

• Maven Clinical Cloud Proprietary end-to-end clinical trial operations and data management cloud platform supporting pharmaceutical, biotech, and medical device companies across the clinical lifecycle from protocol design to regulatory submission and commercialization.
• Maven eRecruitment Online clinical trial subject recruitment platform that enables efficient enrollment of participants for clinical studies, particularly in decentralized clinical trial settings.
• Maven Safety Drug safety and pharmacovigilance management solution that reports adverse events and safety data to regulatory agencies following ICH E2B(R3) standards, with self-developed FDA AS2 gateway integration.
• Maven Converter AI-powered solution that automatically transforms raw EDC clinical data into CDISC SDTM international standards format with statistical analysis automation for regulatory submissions.
• Maven Coder Express AI-powered medical coding solution using Amazon Bedrock and NLP for automated MedDRA coding of adverse events and medical terminology in clinical trial data.
• Maven TMF Cloud-based electronic Trial Master File (eTMF) solution for managing and organizing clinical trial documentation with improved operational efficiency.
• Maven CDMS (Clinical Data Management System) Clinical trial data collection and management system for gathering and managing clinical trial data throughout the study lifecycle.
• Maven eCOA (Electronic Clinical Outcome Assessment) Electronic Clinical Outcome Assessment solution for decentralized clinical trials (DCT), enabling remote patient-reported data collection and monitoring.
• Maven VDR (Virtual Data Room) Virtual Data Room solution optimized for pharmaceutical and biotech licensing, enabling secure document and data exchange with enhanced information asset security.
• Maven Builder User-friendly clinical database design solution for efficient setup and configuration of clinical trial data systems.
• Professional Services On-demand solutions covering business strategy, product development, clinical research, regulatory approval (FDA, CE, MFDS), and licensing-out for pharmaceutical, biotech, and medical device products.
• AWS MSP Service AWS Managed Service Provider offering cloud operations support — security, cost optimization, and scalability — for pharmaceutical and biotech digital transformation.

Quantifiable outcome

• Revenue growth of 500% in the previous year
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature10 records

Partnerships

23 partnerships are on record, tiered core and minor.

• NavercoreStrategic or Co-development Partner · 18 June 2026AI-based digital healthcare global expansion collaboration. Combines JNPMEDI's clinical trial platform with Naver's AI technology to strengthen global competitiveness and investment cooperation for promising domestic companies.
• 휴로틱스 (Hurotics)coreStrategic or Co-development Partner · 1 May 2026Joint clinical trials and global certification for soft wearable rehabilitation robot 'H-Medi' based on Maven Clinical Cloud. Focus on hip surgery rehabilitation, new medical technology certification, and global market entry.
• 제이앤피메디파트너스coreStrategic or Co-development Partner · 10 September 2025Demo Day 2025 event for pharma/biotech/medical device startups and domestic/international investors. Biotech Ventures School collaboration with FMI.
• 오니메이드 & 쿠리오사minorStrategic or Co-development Partner · 28 August 2025Third Daewon Pharmaceutical Open Innovation program selection for clinical data solutions.
• Daewoong PharmaceuticalminorStrategic or Co-development Partner · 13 August 2025Open innovation collaboration with Daewoong Pharmaceutical for clinical data solutions.
• MCRA & IQVIAcoreStrategic or Co-development Partner · 26 June 2025First practical workshop collaboration for domestic medical device companies' US market entry. Covers FDA approval, insurance reimbursement, and clinical strategy.
• 오픈리서치minorStrategic or Co-development Partner · 9 May 2025AI-based medical information intelligence joint research MOU for data-based innovation technology development.
• 경희대학교 약학대학minorStrategic or Co-development Partner · 23 December 2024Regulatory science and pharmacy talent development MOU including practical training, seminars, guest lectures, and talent recruitment programs.
• 비에스리서치 (BS Research)coreStrategic or Co-development Partner · 17 December 2024Joint clinical research and global market entry for biocompatibility surface modification technology. Includes domestic clinical trials, CE/FDA certification preparation, and breast implant development.
• 미래의학연구재단 (FMI)coreStrategic or Co-development Partner · 16 December 2024Clinical approval and investment cooperation for pharmaceutical and medical device companies. Focus on commercialization support and global market competitiveness.
• 원주의료기기테크노밸리 (WMIT)minorStrategic or Co-development Partner · 26 November 2024Gangwon region medical device industry development promotion. Includes information sharing, joint software development, healthcare data legal advice, and consulting support.
• 유타대학교 아시아캠퍼스minorStrategic or Co-development Partner · 4 July 2024Korea-US pharma/biotech industry activation partnership using global networks for clinical trial and FDA approval support.
• MCRAcoreStrategic or Co-development PartnerCollaboration with global regulatory specialist MCRA in the US market. FDA reviewer recruitment as foundation for various vendor partnerships for local operations.
• 마이크로트 (Microt)coreStrategic or Co-development PartnerFDA 510(k) approval collaboration for A-Stream micro glaucoma implant using Maven Clinical Cloud for clinical data management and regulatory compliance.
• 메디라마coreStrategic or Co-development PartnerAnti-cancer drug development full-cycle service combining JNPMEDI's Maven Clinical Cloud with Medirema's ABCD platform. End-to-end drug development support.
• KIMCocoreStrategic or Co-development PartnerGlobal new drug R&D platform development partnership for domestic biotech industry international competitiveness.
• 솔루엠 헬스케어minorStrategic or Co-development PartnerCancer diagnosis solution development partnership for AI-based diagnostic technology collaboration.
• 넥스트바이오메디컬minorStrategic or Co-development PartnerGlobal competitiveness enhancement and technology cooperation for endoscopy AI development.
• 아방스 클리니컬 (Avance Clinical)coreStrategic or Co-development PartnerGlobal clinical trial competitiveness enhancement MOU with Australian CRO. Support for domestic pharma/biotech companies' Australian early-stage clinical trials and global expansion.
• CMAX Clinical ResearchminorStrategic or Co-development PartnerKorea-Australia clinical trial business expansion MOU with Australia's largest clinical research center.
• ProScientominorStrategic or Co-development PartnerMOU for joint solution expansion and service enhancement in the US market with US-based CRO.
• 한림대학교 산학협력단minorStrategic or Co-development PartnerThree-party MOU including Hallym University Chuncheon Sacred Heart Hospital for CRO professional talent development and medical industry advancement.
• 강원대학교 산학협력단minorStrategic or Co-development PartnerBio innovation startup ecosystem activation and global bio industry development MOU.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Saama Technologies: AI-driven clinical trial data management and analytics platform; closely comparable to JNPMEDI's positioning around AI-augmented clinical data workflows and CDISC-ready pipelines.
• Signant Health: Provides eCOA, EDC, IRT, and patient engagement solutions for clinical trials. Direct overlap with Maven eCOA, CDMS, and decentralized trial offerings.
• Clario: Specialist in eCOA, cardiac safety, and clinical endpoint technology — directly comparable to JNPMEDI's Maven eCOA module and DCT-related capabilities.
• Medidata Solutions (Dassault Systèmes): Rave EDC, CTMS, eCOA and the Medidata AI Intelligent Trials suite directly compete with Maven CDMS, eCOA, and AI-driven automation. Closest comparable product set in clinical trial informatics.
• ArisGlobal: Life sciences platform covering pharmacovigilance (LifeSphere Safety), regulatory, and clinical operations. Closely comparable to JNPMEDI's Maven Safety and broader regulatory-focused modules.
• Medrio: Cloud-native EDC and eClinical platform for Phase I-III trials, including ePRO/eCOA modules. Comparable to Maven CDMS for mid-market sponsors with simpler, faster deployment.

Emerging players

• Castor: Modern cloud EDC platform focused on accessibility and decentralized trials. Smaller and more focused than JNPMEDI but similar in targeting digital-first sponsors and DCT use cases.

Broad incumbents

• IQVIA: Global CRO with proprietary clinical technology (EDC, analytics) and a partner of JNPMEDI for US market workshops. Overlaps with JNPMEDI on both the CRO services side and the technology platform side.
• Veeva Systems: Largest pure-play life sciences cloud platform with Veeva Vault CTMS, eTMF, and CDB offerings that directly overlap with JNPMEDI's Maven modules. Far larger and broader portfolio, but a benchmark competitor in regulated pharma cloud.
• Oracle Clinical One: Oracle's unified EDC/CTMS/eTMF platform competes head-to-head with Maven Clinical Cloud, with Oracle's enterprise sales reach and broader life sciences portfolio as advantages.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCijYQc2EjHxe2MCpVEnRKqw
• LinkedInlinkedin.com/company/jnpmedi

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries2 records

Funding overview

Funding rounds7 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JNPMEDI